|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
| PMC |
1064873 |
Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytoki |
35.9 KB |
2020-09-18 |
|
42 |
|
32,558 |
| PMC |
7205724 |
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppr |
29.5 KB |
2020-12-29 |
|
40 |
|
9,252 |
| PMC |
1064895 |
Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor κB-depend |
29.3 KB |
2020-09-18 |
|
40 |
|
23,205 |
| PMC |
7199903 |
Site-specific glycan analysis of the SARS-CoV-2 spike
SARS-CoV-2 spike protein, elaborated
Vaccine |
17.9 KB |
2020-09-27 |
|
39 |
|
5,029 |
| PMC |
3589482 |
The Transcription Factor C/EBP-β Mediates Constitutive and LPS-Inducible Transcription of Murine Ser |
47 KB |
2020-09-18 |
|
38 |
|
27,774 |
| PMC |
3218875 |
Negative regulation of NF-κB and its involvement in rheumatoid arthritis
Abstract
The transcription |
33.9 KB |
2020-09-18 |
|
38 |
|
23,392 |
| PMC |
7253482 |
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Abstract
Severe acute |
37 KB |
2020-09-27 |
|
37 |
|
8,508 |
| PMC |
7228307 |
Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
FcγR an |
60.9 KB |
2020-09-27 |
|
37 |
|
6,339 |
| PMC |
7441788 |
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
J. SUN ET AL |
42.1 KB |
2020-09-27 |
|
37 |
|
4,581 |
| PMC |
1472690 |
β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflamm |
41.2 KB |
2020-10-02 |
|
37 |
|
27,057 |
